Comparative Studies of Disordered Proteins with Similar Sequences: Application to Aβ40 and Aβ42

• Published in: Biophysical journal Vol. 104; no. 7; pp. 1546 - 1555
• Main Authors: Fisher, Charles K., Ullman, Orly, Stultz, Collin M.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 02.04.2013; The Biophysical Society
• Subjects: Amino Acid Sequence; Amyloid beta-Peptides - chemistry; Models, Molecular; mutants; mutation; neurodegenerative diseases; Peptide Fragments - chemistry; Protein Multimerization; Protein Structure, Secondary; Protein Unfolding; proteins; Proteins and Nucleic Acids; uncertainty
• ISSN: 0006-3495; 1542-0086; 1542-0086
• DOI: 10.1016/j.bpj.2013.02.023

Quantitative comparisons of intrinsically disordered proteins (IDPs) with similar sequences, such as mutant forms of the same protein, may provide insights into IDP aggregation—a process that plays a role in several neurodegenerative disorders. Here we describe an approach for modeling IDPs with similar sequences that simplifies the comparison of the ensembles by utilizing a single library of structures. The relative population weights of the structures are estimated using a Bayesian formalism, which provides measures of uncertainty in the resulting ensembles. We applied this approach to the comparison of ensembles for Aβ40 and Aβ42. Bayesian hypothesis testing finds that although both Aβ species sample β-rich conformations in solution that may represent prefibrillar intermediates, the probability that Aβ42 samples these prefibrillar states is roughly an order of magnitude larger than the frequency in which Aβ40 samples such structures. Moreover, the structure of the soluble prefibrillar state in our ensembles is similar to the experimentally determined structure of Aβ that has been implicated as an intermediate in the aggregation pathway. Overall, our approach for comparative studies of IDPs with similar sequences provides a platform for future studies on the effect of mutations on the structure and function of disordered proteins.